Illumina's Bid For $25M Over DNA Tech Patents Goes To Jury

By Hannah Albarazi · November 22, 2021, 10:04 PM EST

Attorneys for Illumina urged a California federal jury during closing arguments Monday to find that its Chinese rival BGI Genomics and its subsidiaries owe $25.4 million for willfully infringing Illumina patents...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Illumina, Inc. et al v. BGI Genomics Co., Ltd et al

Case Number

3:19-cv-03770

Court

California Northern

Nature of Suit

Patent

Date Filed

June 27, 2019